Navigation Links
MedAssurant's Dr. Keith Dunleavy to Present at AHIP's Institute 2008

Industry Expert To Discuss The Benefits of Improved Patient Medical Data

ANNAPOLIS, Md., May 27 /PRNewswire/ -- MedAssurant, Inc., a leading medical informatics solutions provider, announced today that MedAssurant President and CEO, Dr. Keith Dunleavy will be presenting at AHIP's Institute 2008 to be held June 18-20, 2008 at the Moscone Center West in San Francisco.

The symposium, "Patient Healthcare Data Supersets: Improving Outcomes and Financial Performance," will be held at 7:45 am PDT on Thursday June 19, 2008. Dr. Dunleavy will discuss the pieces of patient medical data needed to drive improvements, how improved patient-specific data benefits the patient, the care provider, and the payor, and how necessary data elements can be efficiently discovered, aggregated, and made assessible in such a way as to efficiently achieve desired benefits of quality of care and cost of care to all parties.

Dr. Dunleavy serves as President and CEO of MedAssurant, Inc. and holds over 16 years of health care experience. During his tenure, Dr. Dunleavy has focused on addressing the rising role of patient-specific healthcare care; the coordinated integration, abstraction and analysis of its discordant sources; and the resulting realization of material improvements in health care outcomes and financial performance. Dr. Dunleavy has authored and co-authored a number of scientific journal articles, abstracts and proprietary research papers and has presented his work at multiple national and international conferences.

In addition, for persons interested in how MedAssurant's healthcare data analytics and empowered healthcare solutions are helping to transform the healthcare industry, MedAssurant will be available in the exhibit hall at Booth #423.

For more information on this AHIP event, please visit:

For information regarding the MedAssurant case study, "Patient Data Supersets: Improving Outcomes and Financial Performance", please visit:

About MedAssurant, Inc.

MedAssurant, Inc. is a leading medical informatics service provider focused on the importance of healthcare data and its ability to drive dramatic, objective improvements in clinical and quality outcomes, care management, and financial efficiencies throughout the healthcare community. Proprietary healthcare datasets, abstraction, and analysis capabilities, combined with a national infrastructure of leading-edge technology, clinical prowess, and deep human resources empowers MedAssurant's new generation of healthcare assessment and improvement through highly informed solutions. In partnership with many members of the healthcare community, MedAssurant provides local, regional, and nationwide health insurance plans, hospitals, pharmaceutical companies, regulatory bodies, government organizations, physician organizations, and their many coveted patients with powerful turnkey solutions to address matters of clinical outcomes analysis, quality of care, cost improvement, risk adjustment, disease management, utilization, and healthcare data verification. Driven by a mission to improve today's healthcare landscape, the employees of MedAssurant proudly apply care, ingenuity, and dedication to delivering a new approach to healthcare -- one driven by data and insight -- one resulting in meaningful action.

SOURCE MedAssurant, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Keith Denner Extends Current Technologys Chairman and CEO Options
2. Atlanta Falcons Linebacker Keith Brooking Prepares to Run for Something Better at ING Georgia Marathon
3. Therap Services Welcomes Anna Keith to the US Customer Support Team
4. Viant Appoints Keith Vangeison as Executive Vice President of Network Development
5. Verus Pharmaceuticals Announces Promotion of Robert W. Keith to Chief Executive Officer
6. Keith Taft Named General Manager of UltraTape Industries
7. AMN Healthcare Services to Present at the BMO Capital Markets 2008 Healthcare Staffing Forum
8. ev3 Inc. to Present at the Goldman Sachs Twenty-Ninth Annual Global Healthcare Conference
9. Pharsight Invited to Present on Modeling and Simulation at ARCS Australia Scientific Congress
10. Watson to Present at the UBS Global Specialty and Generic Pharmaceuticals Conference
11. Bioniche Presents Pre-Clinical Research at Two International Conferences
Post Your Comments:
(Date:6/26/2016)... (PRWEB) , ... June 26, 2016 , ... ... fertility once they have been diagnosed with endometriosis. These women need a treatment ... also require a comprehensive approach that can help for preservation of fertility and ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency Room , ... Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. , ... our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director of First ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published ... unfamiliar with. The article goes on to state that individuals are now more comfortable ... less common operations such as calf and cheek reduction. The Los Angeles area medical ...
(Date:6/24/2016)... ... June 24, 2016 , ... Global law firm Greenberg Traurig, P.A. announced that ... chosen by their peers for this recognition are considered among the top 2 percent ... special honors as members of this year’s Legal Elite Hall of Fame: Miami ...
(Date:6/24/2016)... ... June 24, 2016 , ... EB Medicine presented its first-ever ... Medicine conference in Ponte Vedra Beach, FL. The awards honor the outstanding work ... Practice and Pediatric Emergency Medicine Practice. , “With this award, we recognize ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016  Consumers have taken ... regulators/payers have placed more emphasis on patient outcomes. ... support programs in the pharmaceutical industry have evolved ... Consequently, pharmaceutical companies are focusing on becoming more ... providing products and services that improve health. ...
(Date:6/24/2016)... 24, 2016  Global Blood Therapeutics, Inc. (GBT) (NASDAQ: ... novel therapeutics for the treatment of grievous blood-based ... closing of its previously announced underwritten public offering ... public offering price of $18.75 per share. All ... by GBT. GBT estimates net proceeds from the ...
(Date:6/24/2016)... Dublin - ... " Global Markets for Spectroscopy Equipment" report ... This report focuses on the global market of ... applications in various applications. The report deals with spectroscopy ... industries: pharmaceutical and biotechnology, food and beverage, and environmental ...
Breaking Medicine Technology: